Aurora, Denver’s biggest suburb, is the epicenter of life sciences research: a 256-acre complex that’s home to the University of Colorado’s Anschutz Medical Campus, which receives $700 million in annual grant funding. The center helps shorten the timeline from drug discovery to treatment, aiding startups and existing companies to get breakthrough medications to patients faster.
New robotic instrumentation is expected to speed up the discovery of new pharmaceuticals and treatments. Through screening imaging cells, and patient cultures, it’s hoped that the new process will speed up treatments for cancer and Alzheimer’s disease.
The automated technology could cut the screening time for new drug therapies by half. That means therapies and pharmaceuticals could be ready for patients faster than ever before.
This new screening and imaging technology will be applied to both small molecule and biologic development and will position the Anschutz Medical Campus for the next generation of translational discovery where speed and efficiency are essential.
Not only will university researchers be able to use the new screening and imaging equipment, but also the bioscience community and startups that are working with Anschutz and being born out of research happening there.
The University of Colorado Anschutz Medical Campus in Aurora announced the addition of new technology that researchers say could cut the screening time for new drug therapies in half.
The University of Colorado Anschutz Medical Campus announced a new robotic screening and imaging technology today marking a major breakthrough in the detection and treatment of disease.
The University of Colorado Anschutz Medical Campus announced a new robotic screening and imaging technology today marking a major breakthrough in the detection and treatment of disease.